Market capitalization | DKK26.85b |
P/E (TTM) P/E ratio | 72.46 |
P/S ratio (TTM) P/S ratio | 4.60 |
Dividend yield | 0.38% |
Last dividend (FY24) | DKK0.38 |
Revenue growth (TTM) Revenue growth | 14.96% |
Revenue (TTM) Revenue | DKK5.83b |
EBIT (operating result TTM) EBIT | DKK792.00m |
Free Cash Flow (TTM) Free Cash Flow | DKK410.00m |
As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.
10 Analysts have issued a Ambu forecast:
10 Analysts have issued a Ambu forecast:
Mar '25 |
+/-
%
|
||
Revenue | 5,834 5,834 |
15%
15%
|
|
Gross Profit | 3,516 3,516 |
20%
20%
|
|
EBITDA | 1,003 1,003 |
40%
40%
|
EBIT (Operating Income) EBIT | 792 792 |
56%
56%
|
Net Profit | 370 370 |
1%
1%
|
In millions DKK.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services. It operates through the following segments: Anaesthesia; Patient Monitoring & Diagnostics; and Visualisation. The Anaesthesia segment offers products from resuscitators, face masks, and laryngeal masks to the single use flexible intubation scope. The Patient Monitoring & Diagnostics segmet provides electrodes for cardiology, neurophysiology, and polysomnography. The Visualisation segment includes single-use visualisation devices, which are used in single lung ventilation procedure, or a bedside bronchoscopy procedure in the intensive care unit . The company was founded by Holger Hesse in 1937 and is headquartered in Ballerup, Denmark.
Head office | Denmark |
CEO | Britt Jensen |
Employees | 5,000 |
Founded | 1937 |
Website | www.ambu.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.